Menopause Hormone Therapy and Dementia: What the Research Actually Shows

If you've spent any time on social media lately, you've probably seen confident claims that menopause hormone therapy (MHT) during menopause protects your brain from dementia. Or, just as dramatically, that without it, your brain is in serious trouble. As a physician who cares deeply about educating menopausal women about their bodies, I want to walk you through what the research actually shows, because the real answer is both more nuanced and, ultimately, more honest than what tends to go viral.

Why Do Scientists Think Menopause Might Affect Dementia Risk?

Dementia is more common in women overall, in part because women live longer than men. Whether women have a higher age-adjusted risk (meaning, comparing women and men at the same age) is still an area of active study. But the disparity in absolute numbers has long led scientists to ask whether the hormonal changes of menopause play a role. It's a completely reasonable question to ask.

Estrogen has known effects in the brain: it supports blood flow, influences inflammation, and plays a role in how neurons communicate and maintain energy use. When estrogen drops during menopause, brain metabolism does shift. Researchers have been asking for decades whether those changes translate into long-term cognitive risk, and whether hormone therapy (MHT) might prevent it. But biologic plausibility doesn't always translate into clinical benefit. That's where careful human studies matter.

This is genuinely important science. It deserves rigorous investigation. And that rigor is exactly what's been missing, until now.

What a Major New Review Found

A major new systematic review and meta-analysis, published in The Lancet Healthy Longevity in late 2025, set out to answer the relationship between MHT and dementia as carefully as possible. Led by researchers at University College London, it pulled together data from over one million women.

Here's what made this review different from others you may have heard about: the authors only included high-quality studies, specifically randomized trials and well-designed prospective observational studies where women were actually followed over time. They excluded the kinds of studies that are easy to do but hard to interpret: ones where MHT use was captured with a simple yes/no question (with no information about what type of hormone, what dose, or for how long), or where dementia diagnoses relied on administrative or billing data without clear clinical validation.

This matters because imprecise data leads to imprecise conclusions. If you don't know exactly what someone took, or whether they truly developed dementia, conclusions become unreliable, and benefits are easy to overestimate.

After applying these strict criteria, 15 studies made it into the final review, and 10 into the meta-analysis. Their conclusion? The review did not find consistent evidence that MHT meaningfully raises or lowers the risk of mild cognitive impairment or dementia in postmenopausal women. The authors noted that the certainty of evidence ranged from moderate to very low across the different analyses, meaning confidence in the estimates is limited and firm conclusions in either direction aren't possible.

Small signals in both directions did appear in different analyses, but these were inconsistent and often trivially small. Nothing that would justify changing current clinical practice or guideline recommendations.

It's also worth noting that earlier randomized trial data, including the Women's Health Initiative Memory Study, raised concerns about increased dementia risk when hormone therapy was initiated in women age 65 and older. That's one reason current recommendations emphasize both the timing of MHT and the clinical indication for starting it.

Why Do Some Studies Show a Benefit?

You may have seen headlines about other recent reviews, notably ones from 2023 and 2025, that found a modest protective effect of estrogen-only therapy on dementia risk. These are real papers, and they're worth understanding in context.

Want to read more?

Subscribe to purelymenopause.com to keep reading this exclusive post.

Subscribe Now